Helicon has identified Emergency Medicine, General and Cosmetic Surgery and Oncology markets as high potential segments in China and is seeking products with a strategic fit to the existing portfolio.

N/A

Helicon is positioned to support potential partners with the following services to enter the China and other North Asian markets:

- Local market knowledge and connections.

- Connections to regulatory agencies and coordination of the regulatory process.

- Coordination of clinical trials should these be required for product registration.

- Development and implementation of local pre marketing, PR and launch programs based on local market research.

- Development and implementation of expert education and clinical support programs.

- Logistics and customer service management to ensure product gets to the customer when required.

- A communication bridge to local customs and practices.

Helicon also recognises the risks and challenges of doing business in emerging markets and provides unique and favourable terms to its partners to manage the "Country Risk".

Preregistration

Helicon is seeking partners wishing to commercialise their product in China and other North Asian markets. Helicon has a preference for medium to longer term exclusive licensing arrangements.